Meet the New Face of Science at Mission: Cure Meet Lola Rahib, Ph.D. Lola recently joined Mission: Cure as vice president of translational research to move our “cure strategy” forward. Lola has a Ph.D. in biomedical engineering, expertise in pancreatic cancer, and a commitment to improving patients’ lives. “I am impressed by how much Mission:
Exciting Updates from Mission: Cure Read More »
We are delighted to announce that Mission: Cure has been selected as one of 20 patient-led organizations to join the Rare As One Network. The Network will provide much-needed support by offering new tools, funding, and capacity-building support and training that will further Mission: Cure’s work providing resources to patients and family members, building a better care model,
Mission: Cure Selected to Join The Chan Zuckerberg Initiative’s Rare As One Network Read More »
On June 19th of every year, we commemorate the end of slavery in the United States. In the last hundred years, the healthcare field has made great strides in treating disease, yet many people still receive poor and unequal care. Compared to white people in the United States, people of color have less access to
Our Commitment to Diversity, Equity, and Inclusion Read More »
Mariel Priven is a rising junior at Tufts University majoring in Community Health and pursuing minors in Economics and Latin American Studies. Mariel is passionate about health equity, journalism, and learning languages. She joined Mission: Cure to contribute to its goals of developing effective patient-centered care and improving the lives of those with pancreatitis. Mariel
Introducing Mission: Cure’s 2021 Summer Intern Cohort Read More »
Last year, the American College of Gastroenterology (ACG) published clinical guidelines to provide an evidence-based practical approach to the diagnosis and management of chronic pancreatitis for the general gastroenterologist. We, at Mission: Cure, commend the efforts of the authors and believe that these guidelines are an important step forward for pancreatitis patients who continue to seek a
We are elated to announce that Healx, an AI-powered technology company that shares our passion for patient-centered care, has chosen to team up with Mission: Cure to help find a cure for chronic pancreatitis! Mission: Cure was chosen from among many rare disease organizations to be part of Healx’s Rare Treatment Accelerator Program (RTA) with
During our 2020 Moments of Hope party, we asked patients to submit the names of care providers that gave them a Moment of Hope during their disease journey. Pancreatitis is a commonly misunderstood disease, even in the medical community. New science has revealed that chronic pancreatitis is not caused by alcoholism, but rather a combination of environmental and genetic factors –
Exceptional Pancreatitis Care Providers Read More »
The Collaborative Alliance for Pancreatic Education and Research (CAPER) Board of Directors is delighted to announce the election of Eric Golden as Chair of the CAPER Board. Mr. Golden is the Founder and Managing Director of Fluential Partners, LLC, a boutique investment bank. Previously, he has served in roles ranging from CEO of a startup
Mission: Cure Co-Founder Eric Golden Elected Chair of CAPER Board Read More »
Having chronic pancreatitis increases the risk of pancreatic cancer. According to Dr. Randall Brand, Gastroenterologist and head of the early pancreatic cancer detection program at the University of Pittsburgh Medical Center, people with chronic pancreatitis have approximately a five percent chance of developing pancreatic cancer over a 20-year period. [1] However, recent research has shown
New Pancreatic Cancer Screening Guidelines: What Pancreatitis Patients Need to Know Read More »
Pancreatitis Externally-Led Patient-Focused Drug Development Meeting Mission: Cure was one of many patient advocacy nonprofit organizations that participated in the development of the very first Voice of the Patient Report, a months-long project led by the National Pancreas Foundation. In March, during the Patient-Focused Drug Development (PFDD) meeting, Co-Founder and pancreatitis patient Eric Golden shared
Drug Development With a Patient Focus Read More »
Before You Go
Stay up-to-date on the latest Mission: Cure news and developments in pancreatitis care.
